Albert E Pekary

US Patent:

20020151502, Oct 17, 2002

Filed:

Nov 14, 2001

Appl. No.:

10/002878

Inventors:

Albert Sattin - Los Angeles CA, US
Albert Pekary - Culver City CA, US
Robert Lloyd - Duluth MN, US

International Classification:

A61K038/06
C07K005/08

US Classification:

514/018000, 530/331000

Abstract:

Provided are pharmaceutical preparations including a manufactured peptide having the formula pGlu-R-Pro, wherein Ris Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier, and methods of treatment of neurological and neurobehavioral disorders therewith.

US Patent:

20050009753, Jan 13, 2005

Filed:

Aug 18, 2004

Appl. No.:

10/922476

Inventors:

Albert Sattin - Los Angeles CA, US
Albert Pekary - Culver City CA, US
Robert Lloyd - Duluth MN, US

International Classification:

A61K038/05

US Classification:

514018000, 530331000

Abstract:

Provided are methods of treatment of neurological and neurobehavioral disorders utilizing pharmaceutical preparations including a manufactured peptide having the formula pGlu-R-Pro, wherein Ris Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.

US Patent:

20050233973, Oct 20, 2005

Filed:

Sep 13, 2004

Appl. No.:

10/940202

Inventors:

Albert Sattin - Los Angeles CA, US
Albert Pekary - Culver City CA, US
Robert Lloyd - Duluth MN, US

International Classification:

A61K038/05

US Classification:

514018000

Abstract:

Provided are methods of treatment of neurological and neurobehavioral disorders, including antidepressants for use in treatment of depression and related disorders, utilizing pharmaceutical preparations including a manufactured peptide having the formula pGlu-R-Pro, wherein Ris Glu, Phe, Leu, Tyr, Lys or Val, and preferably Gly, Lys, Leu or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.

US Patent:

6475989, Nov 5, 2002

Filed:

Oct 9, 1998

Appl. No.:

09/169657

Inventors:

Albert Sattin - Los Angeles CA 90025
Albert E. Pekary - Culver City CA 90230
Robert L. Lloyd - Duluth MN 55805

International Classification:

A61K 3806

US Classification:

514 18, 530331

Abstract:

A tri-peptide drug for treatment of neurological and neurobehavioral disorders of a mammal, such drug being derived from the following formula: pGlu-X-Pro-NH , wherein the internal amino acid (X) is a non-histadine amino acid. Methods of treatment of neurological disorders using the tri-peptide, including as an adjunct, synergist or stand-alone therapy, in oral, parenteral, intranasal, transcutaneous, or rectal forms.